臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yang p c"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 381-405 / 2713 (共109頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-17T05:56:11Z	Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration	Lee M.-R.; LI-TA KENG; Shu C.-C.; Lee S.-W.; Lee C.-H.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-09-17T05:41:27Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; KAI-LUN YU; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2021-09-17T03:21:16Z	Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model	Chien L.-H.; Chen C.-H.; Chen T.-Y.; Chang G.-C.; Tsai Y.-H.; Hsiao C.-F.; Chen K.-Y.; Su W.-C.; Wang W.-C.; Huang M.-S.; Chen Y.-M.; Chen C.-Y.; SHENG-KAI LIANG; Chen C.-Y.; Wang C.-L.; Lee M.-H.; Chung R.-H.; Tsai F.-Y.; Hu J.-W.; Katki H.A.; Chatterjee N.; Chanock S.J.; Rothman N.; Lan Q.; Yang P.-C.; Chen C.-J.; Chang I.-S.; Hsiung C.A.
臺大學術典藏	2021-09-17T02:51:09Z	Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration	MENG-RUI LEE; Keng L.-T.; Shu C.-C.; Lee S.-W.; Lee C.-H.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-09-17T02:51:08Z	Epidemiologic surveillance to detect false-positive Mycobacterium tuberculosis cultures	MENG-RUI LEE; Chung K.-P.; Chen W.-T.; Huang Y.-T.; Lee L.-N.; Yu C.-J.; Teng L.-J.; Hsueh P.-R.; Yang P.-C.; Luh K.-T.
臺大學術典藏	2021-09-17T02:51:03Z	Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis	Chung K.-P.; Chang H.-T.; Lo S.-C.; Chang L.-Y.; Lin S.-Y.; Cheng A.; Huang Y.-T.; Chen C.-C.; MENG-RUI LEE; Chen Y.-J.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; Ho C.-C.; Huang M.-T.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-09-17T02:51:02Z	Non-tuberculous mycobacterial lung disease and copd	Huang C.-T.; MENG-RUI LEE; Shu C.-C.; Wang J.-Y.; Yang P.-C.
臺大學術典藏	2021-09-15T01:20:45Z	Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti-PD1 in Liver Cancer	Ou D.-L.; Tseng S.-J.; Kempson I.M.; CHIA-LANG HSU; Yang P.-C.; Liao Z.-X.
臺大學術典藏	2021-09-04T06:19:14Z	Paratyphoid hepatitis: An emerging clinical entity [5]	Hsueh P.-R.; JIA-HORNG KAO; Chen Y.-C.; Yang P.-C.; Luh K.-T.; Wang T.-K.; Lin S.-F.
臺大學術典藏	2021-09-04T06:12:08Z	Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load	Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; JIA-HORNG KAO; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:34Z	High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma	Yang C.-H.; ANN-LII CHENG; Yeh K.-H.; Yu C.-J.; Lin J.-F.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:28Z	Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer	Yang C.H.; Tsai C.M.; Wang L.S.; Lee Y.C.; Chang C.J.; Lui L.T.; Yen S.H.; Hsu C.; ANN-LII CHENG; Liu M.Y.; Chiang S.C.; Chen Y.M.; Luh K.T.; Huang M.H.; Yang P.-C.; Perng R.-P.
臺大學術典藏	2021-09-01T02:02:18Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:17Z	Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein	Yang C.-H.; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG; Whang-Peng J.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:15Z	Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment	Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:06Z	A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma	Chen Y.-M.; Yu C.-J.; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; ANN-LII CHENG; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:29Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; ANN-LII CHENG; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:28Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:26Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:21Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-08-31T06:42:24Z	Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity	Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; Yang P.-C.; ANN-LII CHENG
臺大學術典藏	2021-08-31T03:33:47Z	Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis	Chung K.-P.; Chang H.-T.; Lo S.-C.; Chang L.-Y.; SHU-YUNG LIN; Cheng A.; Huang Y.-T.; Chen C.-C.; Lee M.-R.; Chen Y.-J.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; Ho C.-C.; Huang M.-T.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-31T03:33:45Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2021-08-24T06:21:32Z	Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial	Chien J.-Y.; MAO-SHIN LIN; Huang Y.-C.T.; Chien Y.-F.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-24T00:33:36Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	YAO-WEN KUO; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; Yang P.-C.

顯示項目 381-405 / 2713 (共109頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2823024
	造訪人次 : 30276168 線上人數 : 1158 教育部委託研究計畫計畫執行:國立臺灣大學圖書館